Multicentric study, open label, uncontrolled phase IV in 30 patients with meibomian glands dysfunction . Its objective is to Collect information from patients and ophthalmologists specialized in ocular surface and eyelids to anticipate how Blephasteam ® can be optimized. This study involves 2 visits, visit of Inclusion, J0, then end of study visit, D21. Between the two visits patients will be treated with Blephasteam ® for 21 days (up to two uses per day) and complete a questionnaire every two days during the first week and then once a week the next two weeks.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
30
Eye lid warming goggles
Hôpital Gabriel Montpied
Clermont-Ferrand, France
C.H.N.O des XV-XX
Paris, France
Hôpital Bichat - Claude Bernard
Paris, France
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.